VIDO-InterVac scientists receive funding from Canadian Swine Health Board

Feb 16, 2012

The two projects funded by the Canadian Swine Health Board are aimed at developing new vaccines for the swine industry including a universal vaccine for swine influenza and an adenovirus based vaccine for a novel vaccine for porcine reproductive and respiratory syndrome virus (PRRSV). Both diseases cause major impacts in the swine industry. The economic impact of the 2009 H1N1 influenza outbreak remain fresh in swine prodcuers memories, PRRSV causes reproductive failure in breeding stock and respiratory tract illness in young pigs. The Canadian Swine Health Board (CSHB) has a mandate to provide leadership, coordination and support in the management of the health of the Canadian swine herd. Through an inclusive approach involving all stakeholders, the CSHB will work to develop and implement a long term strategy for control of diseases in the hog industry.